Guidelines
2017 Canadian Guideline for Opioids for Chronic Pain
The 2017 Canadian Guideline for Opioid Therapy and Chronic Non-Cancer Pain was developed in response to concerns that Canadians are the second highest users per capita of opioids in the world, while the rates of opioid prescribing and opioid-related hospital visits and deaths have been increasing rapidly. The guideline's recommendations for clinical practice have been developed by an international team of clinicians, researchers and patients, led by the Michael G. DeGroote National Pain Centre at McMaster University and funded by Health Canada and the Canadian Institutes of Health Research. The guideline was published by the Canadian Medical Association Journal (CMAJ). The guideline incorporates medical evidence published since the previous national opioid use guideline was made available in 2010. They are recommendations for physicians, but are not regulatory requirements. The guideline does not look at opioid use for acute pain, nor for patients with pain due to cancer or in palliative care, or those under treatment for opioid use disorder or opioid addiction |
|
|
|
|
|
Appendicies- Values and Preferences Statement (English) - Values and Preferences Statement (French) - Conflict of Interest Declaration (Panel) |
Tools- Opioid Tapering (Patient Info English) - Opioid Tapering (Patient Info French) |
2010 -Guideline
[Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain] (2010)
- Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome in Adults (2012. Comprehensive, evidence-based and written by a panel of Canadian experts. Endorsed by the Canadian Pain Society and the Canadian Rheumatology Association)
- Endometriosis: Diagnosis and Management (Journal of Obstetrcs and Gynaecology of Canada, Published July 2010)
- Evidence-based guideline for neuropathic pain interventional treatments: Spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks (Produced by the Canadian Pain Society Neuropathic Special Interest Group. Published in Pain Research & Management. 2012 May-June:; 17(3): 150-158)
- Guideline for Management of Primary Headache in Adults (Published July 2012, Towards Optimized Practice, and Institute of Health Economics, Alberta, Canada)
- Guideline for the Evidence-Informed Primary Care Management of Low Back Pain
(Updated November 2011) - Pharmacological management of chronic neuropathic pain - Consensus statement and guidelines from the Canadian Pain Society (Pain Research & Management Vol 12 No 1 Spring 2007)
The Evidence-Based Recommendations for Medical Management of Chronic Non-Malignant Pain below is a guideline facilitated by the College of Physicians and Surgeons of Ontario (CPSO). It is posted on the National Pain Centre website for historical reference. This Guideline was published in November 2000 and functioned as the opioid guideline for that time. The accompanying document Reference Guide for Clinicians for the Medical Management of Chronic Non-Malignant Pain contains information for clinicians extracted from the 2000 guideline. In May 2010 the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain became the current source for information on opioids. The 2010 Guideline will be updated in five years. - Evidence-Based Recommendations for Medical Management of Chronic Non-Malignant Pain (CPSO 2000) (Opioid chapter replaced by Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain in 2010)
- Reference Guide for Clinicians for the Medical Management of Chronic Non-Malignant Pain (CPSO 2000) (Opioid chapter replaced by Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain in 2010)